RE: To keep growing26 Mar 2014 11:39
I agree. CTS are very low margin and difficult to negotiate; simply because there is not much management to do but to arrange for the delivery and paperwork. However, CTS can bring very high revenue and high profits in absolute number but also distort profit at the end. The SP and GAP revenue streams are the ones to look for and the main competitor in UK that I know of is IDIS but USA companies plays also a big role since the major Pharma Biotech are there.